3 assets in Senile Plaque Formation

Therapeutic assets addressing Senile Plaque Formation, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Donanemab Senile Plaque Formation	Eli Lilly and Company	P3	B (60)
Lenalidomide Senile Plaque Formation	St. Joseph's Hospital and Medical Center, Phoenix	P2	B (57)
Aci-24.060 Senile Plaque Formation	AC Immune SA	P1/2	CCC (48)